OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A Selective Review and Virtual Screening Analysis of Natural Product Inhibitors of the NLRP3 Inflammasome
Sherihan El‐Sayed, Sally Freeman, Richard A. Bryce
Molecules (2022) Vol. 27, Iss. 19, pp. 6213-6213
Open Access | Times Cited: 13
Sherihan El‐Sayed, Sally Freeman, Richard A. Bryce
Molecules (2022) Vol. 27, Iss. 19, pp. 6213-6213
Open Access | Times Cited: 13
Showing 13 citing articles:
Brazilin is a natural product inhibitor of the NLRP3 inflammasome
Emily McMahon, Sherihan El‐Sayed, Jack Green, et al.
iScience (2024) Vol. 27, Iss. 2, pp. 108968-108968
Open Access | Times Cited: 8
Emily McMahon, Sherihan El‐Sayed, Jack Green, et al.
iScience (2024) Vol. 27, Iss. 2, pp. 108968-108968
Open Access | Times Cited: 8
Medicinal chemistry strategies targeting NLRP3 inflammasome pathway: A recent update from 2019 to mid-2023
Meibo Duan, Lei Sun, Xinzi He, et al.
European Journal of Medicinal Chemistry (2023) Vol. 260, pp. 115750-115750
Closed Access | Times Cited: 15
Meibo Duan, Lei Sun, Xinzi He, et al.
European Journal of Medicinal Chemistry (2023) Vol. 260, pp. 115750-115750
Closed Access | Times Cited: 15
Mental Health Disorders Due to Gut Microbiome Alteration and NLRP3 Inflammasome Activation After Spinal Cord Injury: Molecular Mechanisms, Promising Treatments, and Aids from Artificial Intelligence
Pranav Kalaga, Swapan K. Ray
Brain Sciences (2025) Vol. 15, Iss. 2, pp. 197-197
Open Access
Pranav Kalaga, Swapan K. Ray
Brain Sciences (2025) Vol. 15, Iss. 2, pp. 197-197
Open Access
Anti-inflammatory and uric acid lowering effects of Euodiae fructus on hyperuricemia and gout mice
Zhilei Wang, Jingwen Liu, Yu Mou, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
Zhilei Wang, Jingwen Liu, Yu Mou, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
Targeting COVID-19 and varicocele by blocking inflammasome: Ligand-based virtual screening
Haitham Al‐Madhagi, Muhammed Tılahun Muhammed
Archives of Biochemistry and Biophysics (2024) Vol. 759, pp. 110107-110107
Closed Access | Times Cited: 3
Haitham Al‐Madhagi, Muhammed Tılahun Muhammed
Archives of Biochemistry and Biophysics (2024) Vol. 759, pp. 110107-110107
Closed Access | Times Cited: 3
Recent advances in the treatment of gout with NLRP3 inflammasome inhibitors
Ye Tian, Xiaofang He, Ruping Li, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 112, pp. 117874-117874
Closed Access | Times Cited: 3
Ye Tian, Xiaofang He, Ruping Li, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 112, pp. 117874-117874
Closed Access | Times Cited: 3
Repurposing FDA-approved drugs as NLRP3 inhibitors against inflammatory diseases: machine learning and molecular simulation approaches
Vipul Agarwal, Rajesh Haldhar, Abdurahman Hajinur Hirad, et al.
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-13
Closed Access | Times Cited: 2
Vipul Agarwal, Rajesh Haldhar, Abdurahman Hajinur Hirad, et al.
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-13
Closed Access | Times Cited: 2
A comprehensive computational study of Millets derived phytochemicals as potential inhibitors of NACHT domain of NLRP3 inflammasome: Molecular docking, molecular dynamics simulation, MM-PBSA free energy calculation and DFT analysis
Indian Journal of Biochemistry and Biophysics (2024)
Open Access | Times Cited: 2
Indian Journal of Biochemistry and Biophysics (2024)
Open Access | Times Cited: 2
A novel strategy for bioactive natural products targeting NLRP3 inflammasome in Alzheimer’s disease
Zhiyou Yang, Junxin Liu, Shuai Wei, et al.
Frontiers in Pharmacology (2023) Vol. 13
Open Access | Times Cited: 7
Zhiyou Yang, Junxin Liu, Shuai Wei, et al.
Frontiers in Pharmacology (2023) Vol. 13
Open Access | Times Cited: 7
WN1703 alleviates gout symptoms via inflammatory signaling pathways in an acute gout rat model
Fuyao Liu, Xiaodan Lu, Lei Zhang, et al.
Pharmaceutical Science Advances (2024) Vol. 2, pp. 100039-100039
Open Access
Fuyao Liu, Xiaodan Lu, Lei Zhang, et al.
Pharmaceutical Science Advances (2024) Vol. 2, pp. 100039-100039
Open Access
Virtual screening-led design of inhibitor scaffolds for the NLRP3 inflammasome
Sherihan El‐Sayed, Emily McMahon, Sondos Musleh, et al.
Bioorganic Chemistry (2024), pp. 107909-107909
Open Access
Sherihan El‐Sayed, Emily McMahon, Sondos Musleh, et al.
Bioorganic Chemistry (2024), pp. 107909-107909
Open Access
Camellia Sinensis Çaylarındaki Moleküllerin NLRP3 NACHT Domainine İn Siliko Bağlanma Afiniteleri
Zekeriya Düzgün, Birgül Vanizör Kural
Gümüşhane Üniversitesi Sağlık Bilimleri Dergisi (2023) Vol. 12, Iss. 3, pp. 910-917
Open Access
Zekeriya Düzgün, Birgül Vanizör Kural
Gümüşhane Üniversitesi Sağlık Bilimleri Dergisi (2023) Vol. 12, Iss. 3, pp. 910-917
Open Access
Brazilin is a Natural Product Inhibitor of the NLRP3 Inflammasome
Emily McMahon, Sherihan El‐Sayed, Jack Green, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Emily McMahon, Sherihan El‐Sayed, Jack Green, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
